← back to search

Panagiotis Ntziachristos

Ghent University Hospital · BE
Area of research
Molecular Biology · Hematology
Research interest
Research interests include RNA Research and Splicing, RNA modifications and cancer, Acute Myeloid Leukemia Research, and Acute Lymphoblastic Leukemia research.
h-index
28
citations
4,826
works
187
NIH funding
primary concept
email

Recent publications

HNRNPC and m6A RNA methylation control oncogenic transcription and metabolism in T-cell leukemia
Blood 2025cited by 12position: lastdoi
Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory pediatric T-cell acute lymphoblastic leukemia
Leukemia 2025cited by 2position: middledoi
T cell acute lymphoblastic leukemia exploits a neural proinflammatory pathway to colonize the meninges
Journal of Clinical Investigation 2025cited by 0position: middledoi
Chromatin reprogramming and bone regeneration in vitro and in vivo via the microtopography-induced constriction of cell nuclei
Nature Biomedical Engineering 2023cited by 75position: middledoi
CXCR3/CXCL10 Signaling Pathway Drives T-ALL into the CNS/Meningeal Microenvironment
Blood 2023cited by 0position: middledoi
SF3B1 homeostasis is critical for survival and therapeutic response in T cell leukemia
Science Advances 2022cited by 59position: lastdoi
Splicing dysregulation in human hematologic malignancies: beyond splicing mutations
Trends in Immunology 2022cited by 16position: lastdoi
Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia
Science Advances 2022cited by 14position: lastdoi
LKB1/ <i>STK11</i> Is a Tumor Suppressor in the Progression of Myeloproliferative Neoplasms
Cancer Discovery 2021cited by 46position: middledoi
Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia
Nature Genetics 2020cited by 227position: middledoi
Cancer-specific CTCF binding facilitates oncogenic transcriptional dysregulation
Genome biology 2020cited by 125position: middledoi
Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia
Cancer Discovery 2020cited by 101position: lastdoi
Cardiac myocyte KLF5 regulates body weight via alteration of cardiac FGF21
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019cited by 17position: middledoi
Stratification of TAD boundaries reveals preferential insulation of super-enhancers by strong boundaries
Nature Communications 2018cited by 153position: middledoi
USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia
Clinical Cancer Research 2018cited by 92position: lastdoi
HiC-bench: comprehensive and reproducible Hi-C data analysis designed for parameter exploration and benchmarking
BMC Genomics 2017cited by 96position: middledoi
Deregulation of DUX4 and ERG in acute lymphoblastic leukemia
Nature Genetics 2016cited by 318position: middledoi
Emerging concepts of epigenetic dysregulation in hematological malignancies
Nature Immunology 2016cited by 95position: firstdoi
Regulation of transcriptional elongation in pluripotency and cell differentiation by the PHD-finger protein Phf5a
Nature Cell Biology 2016cited by 87position: middledoi
Cardiac Myocyte KLF5 Regulates <i>Ppara</i> Expression and Cardiac Function
Circulation Research 2015cited by 111position: middledoi
Genome-wide Mapping and Characterization of Notch-Regulated Long Noncoding RNAs in Acute Leukemia
Cell 2014cited by 413position: middledoi
From Fly Wings to Targeted Cancer Therapies: A Centennial for Notch Signaling
Cancer Cell 2014cited by 380position: firstdoi
Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia
Nature 2014cited by 375position: firstdoi
Control of Embryonic Stem Cell Identity by BRD4-Dependent Transcriptional Elongation of Super-Enhancer-Associated Pluripotency Genes
Cell Reports 2014cited by 218position: middledoi
The Ubiquitin Ligase FBXW7 Modulates Leukemia-Initiating Cell Activity by Regulating MYC Stability
Cell 2013cited by 372position: middledoi
Notch pathway activation targets AML-initiating cell homeostasis and differentiation
The Journal of Experimental Medicine 2013cited by 151position: middledoi
Higher-Order Looping and Nuclear Organization of Tcra Facilitate Targeted RAG Cleavage and Regulated Rearrangement in Recombination Centers
Cell Reports 2013cited by 41position: middledoi
The RAG2 C-terminus and ATM protect genome integrity by controlling antigen receptor gene cleavage
Nature Communications 2013cited by 38position: middledoi
Mechanisms of Epigenetic Regulation of Leukemia Onset and Progression
Advances in immunology 2013cited by 35position: firstdoi
A new player SETs in myeloid malignancy
Nature Genetics 2013cited by 15position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Iannis Aifantis · NYU Langone Health16 papers (2013–2020)Aristotelis Tsirigos · NYU Langone Health7 papers (2014–2022)Thomas Trimarchi · BridgeBio (United States)6 papers (2013–2020)Charalampos Lazaris · Broad Institute4 papers (2016–2020)Nicholas Jones · The Ohio State University Wexner Medical Center3 papers (2023–2025)Igor Dolgalev · NYU Langone Health2 papers (2014–2016)Eliseo F. Castillo · University of New Mexico2 papers (2023–2025)Yuval Kluger · Yale University2 papers (2013–2013)Stephen P. Hunger · University College London2 papers (2023–2025)Omar Abdel‐Wahab · Presbyterian Hospital2 papers (2013–2016)Ross L. Levine · Leukemia and Lymphoma Society2 papers (2013–2021)Cuijuan Han · Jackson Laboratory2 papers (2020–2022)Monique Nysus · University of New Mexico2 papers (2023–2025)Wojciech Ornatowski · University of Arizona2 papers (2023–2025)Huining Kang · University of New Mexico2 papers (2023–2025)Jasper Mullenders · Hycult Biotech (Netherlands)2 papers (2013–2013)Valentina Serafin · University of Padua2 papers (2020–2022)Konstantinos Drosatos · University of Cincinnati Medical Center2 papers (2015–2019)Ksenia Matlawska‐Wasowska · University of New Mexico2 papers (2023–2025)Katherine E. Zychowski · University of New Mexico2 papers (2023–2025)